TransPerfect Acquires Synterex to Expand Medical Writing Expertise and AI-Enabled Regulatory Solutions
October 1, 2026
TransPerfect announced it has acquired Synterex, a Dedham, Massachusetts-based clinical and regulatory writing and technology-enabled consulting firm serving biotech and pharmaceutical clients. Synterex’s AgileWriter.ai platform supports AI-assisted authoring and regulatory content workflows, which TransPerfect says will integrate into its Life Sciences offerings as a division.
- Buyers
- TransPerfect
- Targets
- Synterex
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Veristat to Acquire Certara Regulatory and Medical Writing Business
April 22, 2026
Healthcare Services
Veristat announced it has entered into a definitive agreement to acquire Certara’s Regulatory and Medical Writing business. The deal is expected to close in Q2 2026 and will add 200+ (approximately 220) medical writing and regulatory experts to expand Veristat’s regulatory writing, submission strategy, and advisory capabilities across the drug development lifecycle.
-
TransPerfect Acquires Unbabel
August 22, 2025
AI & Machine Learning
TransPerfect has acquired Unbabel, a language AI leader, integrating Unbabel's TowerLLM and COMET technologies into its GlobalLink technology stack. Financial terms were not disclosed; Unbabel CEO Vasco Pedro will remain to oversee integration as TransPerfect expands its AI-driven language and localization capabilities.
-
XTM International Acquires Transifex
January 30, 2025
Cloud & SaaS
XTM International has acquired Transifex, a SaaS-based localization and translation management platform. The deal brings Transifex’s AI-driven continuous localization capabilities into XTM’s enterprise-grade translation platform to accelerate real-time, scalable multilingual content delivery for global customers.
-
Syner-G Acquires Impact Pharmaceutical Services
February 1, 2022
Healthcare Services
Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired Impact Pharmaceutical Services, a Research Triangle Park-based provider of medical writing, regulatory strategy, and regulatory publishing services for biotech and pharmaceutical clients. The deal, which closed in late December, expands Syner-G's CMC and regulatory capabilities to better support clients across pre-IND through post-marketing stages; financial terms were not disclosed.
-
TransPerfect Life Sciences Acquires LMK Clinical Research Consulting
December 6, 2021
Healthcare Services
TransPerfect Life Sciences has acquired LMK Clinical Research Consulting, a specialized provider of Trial Master File (TMF) document management, training and consulting services. The acquisition expands TransPerfect's TMF and eTMF capabilities and adds LMK's accredited TMF University training program to TransPerfect's life sciences offerings; financial terms were not disclosed.
-
Syneos Health Acquires Synteract from Amulet Capital Partners
December 10, 2020
Healthcare Services
Syneos Health (NASDAQ: SYNH) has completed the acquisition of Synteract, a full-service contract research organization (CRO) focused on emerging biopharma. The seller was Amulet Capital Partners, which had previously built Synteract through organic investment and add-on acquisitions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.